How is SARS-CoV-2 antibody prevalence changing over time?
Conducting the Multistate Assessment of SARS-CoV-2 Seroprevalence in Blood Donors
Reported cases of COVID-19 represent a subset of total infections because some infected people have mild or no symptoms or do not seek medical care or get tested. Furthermore, the availability of viral testing was limited early on in the COVID-19 pandemic.
The Centers for Disease Control and Prevention’s (CDC’s) Multistate Assessment of SARS-CoV-2 Seroprevalence in Blood Donors tests residual blood donor samples from 60+ metropolitan regions in the U.S. for the presence of SARS-CoV-2 antibodies.
Westat is providing study coordination, data collection and management, and analytical services.
Using U.S. census data, we are weighting the results to extrapolate seroprevalence data from blood donor samples to the general population in the geographic regions in which the blood donors live.
This seroprevalence study will allow CDC to:
- Assess increasing penetrance of SARS-CoV-2 infection into distinct U.S. communities
- Determine overall seroprevalence at various points in time
PerspectiveAccess to Birthing-Friendly Facilities for Maternal Care
Preventable maternal mortality in the U.S. has grown considerably and spurred the federal government into action, most noticeably with the development of the White House…
Expert InterviewExamining Nonpublic Schools and ESSA Program Engagement
Are nonpublic schools making the best use of Title I funds to guarantee low-income students equitable services so that they are career- or college-ready? And…
PerspectiveMaternal Health Awareness Day: January 23, 2024
Access to maternal health care—the theme of this year’s Maternal Health Awareness Day—is not consistently available for many people having a baby in the U.S.…